What this world covers
This world is different from the ten before it. The other worlds are about what you take or do — substances, methods, protocols. Here it's about what makes everything else meaningful in the first place: measuring. Diagnostics and biomarkers are the feedback loop of biohacking. Without them you optimize blind.
This world bundles the diagnostic values with the best evidence and the greatest practical leverage. Four axes structure the field: metabolism (blood glucose, HbA1c, fasting insulin and HOMA-IR, continuous glucose monitoring), cardiovascular risk (lipid profile, ApoB, Lp(a)), silent inflammation and methylation (hs-CRP, homocysteine) and the function and status markers (thyroid panel, liver values, kidney values, complete blood count, ferritin). On top of that come the dynamic markers from wearables and tracking — VO2max, resting heart rate, heart rate variability, body temperature, cycle — which don't come from the lab but serve the same purpose: feeling becomes data.
Why measuring comes before optimizing
There is one principle this world places above all others: You can't optimize what you don't measure. The other ten worlds tell you what works on average across a study population. This world tells you what works for you — and that can only be found out through measurement.
The most common mistake in biohacking is to start with the intervention instead of the measurement. Someone takes an expensive supplement for six months, "because studies" — without ever having measured the marker it's supposed to move, neither before nor after. Whether it changed anything for them remains a matter of faith. Yet the solution is simple and costs a fraction of the supplement budget: measure, intervene, re-measure. Only this closed loop turns a hypothesis into a result.
The principle works in the other direction too. Many effects attributed to expensive substances are in truth the correction of a measurable deficit — a vitamin D level that's too low, a homocysteine value that's too high, an unrecognized insulin resistance. Whoever measures first finds these levers and saves themselves the hunt for effects that aren't happening in their own body at all.
The most important markers
Metabolic axis: HbA1c, insulin & HOMA-IR
Metabolism is the axis where it shows earliest whether an optimization course is on track. HbA1c reflects the average blood sugar of the past roughly three months via the glycation of red blood cells — a robust, well-established value. But it reacts late.
The earlier marker is fasting insulin and the HOMA-IR calculated from it. Insulin often rises for years before blood sugar derails, because the body initially keeps glucose in check with more insulin. Anyone who measures only glucose or HbA1c doesn't see this silent phase. Continuous glucose monitoring (CGM) rounds out the picture with the dynamics: how blood sugar responds to individual meals, stress and sleep. Studies on personalized nutrition show that this response varies strongly between individuals — what's harmless for one person drives a spike in another.
Cardiovascular axis: ApoB instead of LDL-C
For cardiovascular risk the better marker has prevailed: ApoB. Every artery-damaging lipoprotein carries exactly one ApoB molecule, so ApoB measures the actual particle count — and thus what burdens the arterial wall. Classic LDL cholesterol only estimates the cholesterol content and can underestimate the risk when the two values diverge, for instance with insulin resistance or high triglycerides. The full lipid profile stays useful, above all the ratio of triglycerides to HDL as a rough insulin-resistance indicator. Lp(a) is largely genetically determined and should be measured at least once in a lifetime.
Inflammation & methylation: hs-CRP and homocysteine
Silent, low-grade inflammation is a common thread through almost all chronic diseases. High-sensitivity CRP (hs-CRP) makes it measurable: under 1 mg/l is considered favorable, over 3 mg/l elevated. Homocysteine is both an inflammation and a methylation marker — elevated values are associated with cardiovascular and cognitive risks and respond well to the B vitamins B12, folate and B6. An optimal range sits closer to under 8 µmol/l, considerably narrower than the lab range.
Function & status: thyroid, liver, kidney, blood count
The thyroid panel needs more than just TSH: only free T4, free T3 and, if suspected, the antibodies paint the full picture, because a normal TSH can mask weak T4-to-T3 conversion. Liver values — especially GGT — are not only an alcohol but also a metabolic and oxidative-stress marker. Kidney values (creatinine, eGFR, ideally cystatin C) make sure that interventions don't overload the excretory system. The complete blood count plus ferritin uncovers anemias, iron status and a range of silent problems.
Dynamic markers: VO2max, resting heart rate, HRV
Not every biomarker comes from the lab. VO2max — cardiorespiratory fitness — is one of the strongest single predictors of all-cause mortality there is, and directly trainable on top. Resting heart rate and heart rate variability (HRV) from the wearable map the state of the autonomic nervous system: a resting heart rate rising over several days or a falling HRV signals strain, poor recovery or an oncoming infection. Body temperature and cycle tracking provide further layers of context — especially for women, whose biomarkers fluctuate systematically across the cycle.
Reference range is not optimal range
Perhaps the most important concept of this world: the lab reference range and the optimal range are not the same thing. The reference range is statistically defined — usually the interval in which 95% of a reference population falls. But that population is the average of the general public, including many people with suboptimal metabolism.
"Within the normal range" therefore only means "not conspicuous compared to the average" — not "associated with the best outcome". The optimal range, by contrast, is derived from outcome studies: where risk is lowest and function highest. For homocysteine, hs-CRP, HbA1c, ferritin or ApoB, this range often sits noticeably narrower than the lab range. This is exactly the gap biohacking plays in — and exactly the one the platform makes explicitly visible for every marker.
How we rate evidence
With markers, too, we distinguish strictly by evidence density — and above all between two questions that are often confused:
- Predictive value — How well does the marker predict a hard outcome? (e.g. VO2max and mortality, ApoB and cardiovascular events)
- Causal lever — Does shifting the marker also improve the outcome? (supported by Mendelian randomization and intervention studies, e.g. for ApoB)
- Surrogate caution — Some markers correlate with health without their targeted shifting guaranteeing the benefit. We flag that.
A marker that only predicts an outcome is not automatically a marker you should treat. We make this distinction explicit, instead of reflexively declaring every conspicuous value a treatment target.
Most common measurement mistakes
Diagnostics fails more often on methodology than on the marker:
- Not measured fasting where fasting values are needed (glucose, insulin, lipids are otherwise distorted).
- Tested right after hard training — this temporarily raises liver values, CK and CRP and triggers false alarms.
- Single values over-interpreted instead of looking at the trend across several measurements.
- Thyroid judged by TSH only, missing the conversion level.
- LDL-C used where ApoB is discordant and therefore more informative.
- Every possible marker chased instead of consistently following the few with real leverage.
What does not belong in this world
The boundary is clear: this world is the measurement layer, not the intervention layer. The substances and methods you use to move markers live in their own worlds:
- Omega-3, vitamin D, B vitamins for value correction → World 01 (Vitamins & Minerals)
- Fasting, cold, sauna as interventions → World 02 (Methods)
- Thyroid and hormone therapy → World 03 (Hormones)
- Longevity markers in the context of rapamycin & co. → World 06 (Longevity)
The geroscience biomarkers and epigenetic clocks (Horvath, GrimAge, DunedinPACE as aging rate) sit in a special zone: they are measurement instruments and therefore belong here, but their interpretation overlaps heavily with the longevity world. We treat them as a diagnostic tool — with the explicit note that they are surrogates, not the goal itself.
How Biohacking AI operationalizes this
On the platform this world is the common thread that grounds all the others. Four tools interlock:
- The biomarker tracker turns single values into a trend curve and links every change to whatever you adjusted in the meantime — so the effect of an intervention becomes visible instead of believed.
- The studies database shows, for each marker, which interventions demonstrably move it in human studies — and cleanly separates "shifts the value" from "improves the outcome".
- The forum collects anonymized panels and before-and-after trajectories — moderated, with no sales agenda, with optimal instead of just reference ranges.
- The coach reads your values in the context of your stack, flags what's worth a re-test, and says explicitly where the evidence for a recommendation is too thin.
The goal is not "measure more values." The goal is: know the few markers with real leverage, follow them over time and anchor every optimization to a measurement — instead of to a feeling. Diagnostics doesn't replace a medical workup; the platform helps you understand and track your values, not diagnose yourself.